Rapid tests and transfusion safety in Niamey, Niger.

[en] To evaluate the virological safety of blood components provided by the Niamey blood transfusion center after undergoing rapid tests. Samples found negative with rapid tests (n = 222) were screened by the Abbott Prism assay. Positive samples were confirmed by appropriate methods. Of 222 samples, nine (4.1%) were reactive for all markers. After confirmation, seven samples were positive (i.e., 3.2% false-negative results) : five (2.3%) for the surface antigen of hepatitis B (HBsAg) and two (0.9%) for the antibody directed against the hepatitis C virus (HCV-Ab). No false negative results were observed for HIV-Ab (antibody directed against the Human Immunodeficiency Virus). The performance of the rapid tests used in Niamey to screen for transfusion-transmissible infections is not satisfactory, especially for hepatitis B and C. The use of more sensitive tests should be considered to minimize the risk of contaminating patients receiving blood components.

Disciplines :

Public health, health care sciences & services

Author, co-author :

Mayaki, Z.

Seydou, M.

Moutschen, Michel ; Université de Liège - ULiège > Département des sciences cliniques > GIGA-R:Immunopath. - Maladies infect. et médec. inter. gén.

Albert, Adelin ; Université de Liège - ULiège > Département des sciences de la santé publique > Département des sciences de la santé publique

Dardenne, Nadia ; Université de Liège - ULiège > Département des sciences de la santé publique > Biostatistique

Sondag, D.

Gossens, D.

Gérard, Catherine ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, humaines et path.

Language :

English

Title :

Rapid tests and transfusion safety in Niamey, Niger.

Alternative titles :

[en] Tests rapides et securite transfusionnelle a Niamey, Niger.

Publication date :

2017

Journal title :

Médecine et Santé Tropicales

ISSN :

2261-3684

eISSN :

2261-2211

Publisher :

John Libbey Eurotext, France

Volume :

Issue :

Pages :

95-100

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 30 March 2018

Statistics

Number of views

59 (5 by ULiège)

Number of downloads

3 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Organisation Mondiale de la Santé (OMS). Dépistage des ITT dans les dons de sang. Recommandations 2010. www.who.int/bloodsafety/publications/ScreeningDonatedBloodforTTIs-French.pdf.(Consulté le 1er mars 2014.).
World Health Organization Regional Office for Africa, Centers for Disease Control and Prevention, and Association of Public Health Laboratories. Guidelines for Appropriate Evaluations of HIV Testing Technologies in Africa 2003. Centers for Disease Control and Prevention, Atlanta, GA. http://whqlibdoc.who.int/afro/2002/a82959_fre.pdf?ua=1. (Consulté le 22 mars 2014.).
Allain JP, Lee HH. Rapid tests for detection of viral markers in blood transfusion. Expert Rev Mol Diagn 2005; 5: 31-41.
Allain JP, Owusu-Ofori S. Approaches to hepatitis safety in sub-Saharan Africa. ISBT Sci Series 2006; 1: 89-95.
Jayaraman S, Chalabi Z, Perel P, et al. The risk of transfusion-transmitted infections in sub-Saharan Africa. Transfusion 2010; 50: 433-42.
World Health Organisation. Global Database on Blood Safety Summary report 2001-2. 2004b www.who.int/bloodsafety/GDBS_Report_2001-2002. pdf.(Consulté le 16 juillet 2014.).
Organisation Mondiale de la Santé (OMS). Faits et chiffres sur la transfusion sanguine 2013. www.who.int/features/factfiles/blood_transfusion/blood_transfusion/fr/index7.html. (Consulté le 23/04/2014.).
Makuwa M, Souquière S, Niangui MT, et al. Reliability of rapid diagnostic tests for HIV variant infection. J Virol Methods 2002; 103: 183-90.
Laperche S, Boukatou G, Kouegnigan L, et al. Transfusion safety on the African continent: an international quality control of virus testing in blood banks. Transfusion 2009; 49: 1600-8.
Laperche S. for the Francophone African Group for Research in Blood transfusion. Multinational assessment of blood-borne virus testing and transfusion safety on the African continent. Transfusion 2013; 53: 816-26.
Mayaki Z, Dardenne N, Kabo R, et al. Séroprévalence des marqueurs de l’infection chez les donneurs de sang à Niamey (Niger). Rev Epidemiol Sante 2013; 61: 233-40.
O’Connell RJ, Gates RG, Bautista CT, et al. Laboratory evaluation of rapid test kits to detect hepatitis C antibody for use in predonation screening in emergency settings. Transfusion 2013; 53: 505-17.
Rezza G. Determinants of progression to AIDS in HIV-infected individuals: an update from the Italian Seroconversion Study. J Acq Immun Def Synd 1998; 17 (Suppl 1): 13-6.
République du Niger. Enquête Démographique et de Santé et à Indicateurs Multiples (EDSN-MICS IV) 2012. ww.stat-niger.org/statistique/file/EDSN_MICSIV2012/EDSN_MICSIV2012-Rapportdefinitif.pdf. (Consulté le 20 mars 2015.).
Scheiblauer H, El-Nageh M, Nick S, et al. Evaluation of the performance of 44 assays used in countries with limited resources for the detection of antibodies to hepatitis C virus. Transfusion 2006; 46: 708-18.
Pereira FM, Zarife MAS, Reis EAG, Reis MG. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors. Rev Soc Bras Med Tro 2014; 47: 12-7.
Alter MJ, Kuhnert WL, Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention, MMWR Recommandations and Reports 2003; 52: 1-16.
Contreras AM, Ochoa-Jiménez RJ, Celis A, et al. High antibody level: an accurate serologic marker of viremia in asymptomatic people with hepatitis C infection. Transfusion 2010; 50: 1335-43.
Lefrère JJ. Sécurité virale et transplantation d’organes, de tissus et de cellules. Virologie 1998; 2: 227-33.
Page K, Osburn W, Evans J, et al. Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection. Clin Infect Dis 2013; 56: 405-13.
Candotti D, Temple J, Sarkodie F, Allain JP. Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. Virol 2003; 77: 7914-23.
Lee CH, Shin HP, Lee JI, et al. Predicting factors of present hepatitis C virus infection among patients positive for the hepatitis C virus antibody. Clin Mol Hepatol 2013; 19: 376-81.
Owusu-Ofori S, Temple J, Sarkodie F, et al. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005; 45: 133-40.
Wolpaw BJ, Mathews C, Chopra M, et al. The failure of routine rapid HIV testing: a case study of improving low sensitivity in the field. BMC Health Serv Res 2010; 10: 73.
Allain JP, Candotti D, Soldan K, et al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 2003; 101: 2419-25.
Grijalva M, Chiriboga R, Vanhassel H, Arcosteran L. Improving the safety of the blood supply in Ecuador through external performance evaluation of serological screening of blood donors. J Clin Virol 2005; 34 (Suppl 2): 47-52.
Chiu YHC, Ong J, Walker S, et al. Photographed rapid HIV test results pilot novel quality assessment and training schemes. PLoS One 2011; 6. e18294.
Hillaire S. Infection occulte par le virus de l’hépatite B. Hépato-Gastro 2006; 13: 87-90.
Dessie A, Abera B, Walle F, Wolday D, Tamene W. Evaluation of Determine HIV-1/2 rapid diagnostic test by 4th generation ELISA using blood donors’ serum at Felege Hiwot Referral Hospital, northwest Ethiopia. Ethiopian Med J 2008; 46: 1-5.
Orkuma JA, Egesie JO, Banwat EB, et al. HIV screening in blood donors: rapid diagnostic test versus enhanced ELISA. Niger J Med 2013; 23: 192-200. 100